Novo Nordisk is a Denmark-based global healthcare company focused on diabetes, obesity, rare blood disorders and endocrine diseases. Its GLP-1 portfolio gives it a central position in metabolic disease treatment, with growth tied to manufacturing expansion, indication broadening, competition and reimbursement dynamics in major markets.
Publicité
Publicité
RNVO
Rang #4407Novo Nordisk A/S rStock
41.52
09 nov., 20:14 UTC
Novo Nordisk A/S rStock (RNVO)
About
Informations et liens
Site Internet
Contrats
- arbitrum-one:0x0e4…b0ece
- morph-l2:0x6a5…7a4bd
En savoir plus
Données provenant de
